UB Paderborn / Katalog / Suche / in CDI

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

The Lancet (British edition), 2007-03, Vol.369 (9564), p.827-835

2007

Link zum Volltext

Verfügbarkeit prüfen

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

The Lancet (British edition), 2002-07, Vol.360 (9327), p.109-113

2002

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

The New England journal of medicine, 2012-01, Vol.366 (1), p.9-19

2012

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description

BMC cardiovascular disorders, 2012-05, Vol.12 (1), p.33-33, Article 33

2012

Link zum Volltext

Verfügbarkeit prüfen

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

The Lancet (British edition), 2013-03, Vol.381 (9872), p.1107-1115

2013

Link zum Volltext

Verfügbarkeit prüfen

Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

Trials, 2012-01, Vol.13 (1), p.1-1, Article 1

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

European heart journal, 2015-05, Vol.36 (20), p.1264-1272

2015

Link zum Volltext

Verfügbarkeit prüfen

Apixaban versus Warfarin in Patients with Atrial Fibrillation

The New England journal of medicine, 2011-09, Vol.365 (11), p.981-992

2011

Link zum Volltext

Verfügbarkeit prüfen

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper

Journal of the American College of Cardiology, 2012-04, Vol.59 (16), p.1413-1425

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial

Circulation (New York, N.Y.), 2007-10, Vol.116 (15), p.1647-1652

2007

Link zum Volltext

Verfügbarkeit prüfen

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)

The American heart journal, 2012, Vol.163 (1), p.13-19.e1

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial registration: looking back and moving ahead

The Lancet (British edition), 2007-06, Vol.369 (9577), p.1909-1911

2007

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51

Journal of the American College of Cardiology, 2013-07, Vol.62 (4), p.286-290

2013

Link zum Volltext

Verfügbarkeit prüfen

Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes

The New England journal of medicine, 2005-09, Vol.353 (11), p.1095-1104

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trial Registration — Looking Back and Moving Ahead

The New England journal of medicine, 2007-06, Vol.356 (26), p.2734-2736

2007

Link zum Volltext

Verfügbarkeit prüfen

Can we pull the plug on warfarin in atrial fibrillation?

The Lancet (British edition), 2003-11, Vol.362 (9397), p.1686-1687

Verheugt, Freek WA

2003

Link zum Volltext

Verfügbarkeit prüfen

The Role of the Cardiologist in the Primary Prevention of Cardiovascular Disease With Aspirin

Journal of the American College of Cardiology, 2015-01, Vol.65 (2), p.122-124

Verheugt, Freek W.A., MD

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

The Lancet (British edition), 2004-08, Vol.364 (9435), p.675-684

2004

Link zum Volltext

Verfügbarkeit prüfen

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial

The American heart journal, 2015-10, Vol.170 (4), p.683-694.e3

2015

Link zum Volltext

Verfügbarkeit prüfen

Managing Antithrombotic Therapy in Patients With Both Atrial Fibrillation and Coronary Heart Disease

Clinical therapeutics, 2014-09, Vol.36 (9), p.1176-1181

2014

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Journal of the American College of Cardiology, 2007-06, Vol.49 (23), p.2249-2255

2007

Link zum Volltext

Verfügbarkeit prüfen

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2017-02, Vol.103 (4), p.293

2017

Link zum Volltext

Verfügbarkeit prüfen

Routine Angioplasty after Fibrinolysis — How Early Should “Early” Be?

The New England journal of medicine, 2009-06, Vol.360 (26), p.2779-2781

Verheugt, Freek W.A

2009

Link zum Volltext

Verfügbarkeit prüfen

Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?

The American heart journal, 2012-04, Vol.163 (4), p.531-534

Verheugt, Freek W.A., MD, FACC, FESC

2012

Link zum Volltext

Verfügbarkeit prüfen

Low Body Weight and Prescribing DOACs in Atrial Fibrillation

Journal of the American College of Cardiology, 2019-03, Vol.73 (8), p.932-934

Verheugt, Freek W.A.

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)

Clinical trial registration: looking back and moving ahead

Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51

Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes

Clinical Trial Registration — Looking Back and Moving Ahead

Can we pull the plug on warfarin in atrial fibrillation?

The Role of the Cardiologist in the Primary Prevention of Cardiovascular Disease With Aspirin

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

Managing Antithrombotic Therapy in Patients With Both Atrial Fibrillation and Coronary Heart Disease

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Routine Angioplasty after Fibrinolysis — How Early Should “Early” Be?

Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?

Low Body Weight and Prescribing DOACs in Atrial Fibrillation

Aktive Filter

Suchergebnisse filtern